Andrew D. Lipman Sells 2,000 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) Stock

Nu Skin Enterprises, Inc. (NYSE:NUS) Director Andrew D. Lipman sold 2,000 shares of the company’s stock in a transaction dated Thursday, April 25th. The stock was sold at an average price of $12.34, for a total transaction of $24,680.00. Following the transaction, the director now owns 25,225 shares in the company, valued at approximately $311,276.50. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Nu Skin Enterprises Stock Performance

Shares of NYSE:NUS opened at $12.31 on Friday. The stock has a market capitalization of $608.37 million, a P/E ratio of 68.39 and a beta of 1.11. Nu Skin Enterprises, Inc. has a 1-year low of $11.84 and a 1-year high of $40.68. The company has a current ratio of 2.13, a quick ratio of 1.28 and a debt-to-equity ratio of 0.58. The business has a 50-day moving average price of $12.74 and a two-hundred day moving average price of $16.28.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Wednesday, February 14th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.08. The company had revenue of $488.64 million during the quarter, compared to analysts’ expectations of $479.35 million. Nu Skin Enterprises had a return on equity of 10.73% and a net margin of 0.44%. Equities analysts predict that Nu Skin Enterprises, Inc. will post 1.13 earnings per share for the current year.

Nu Skin Enterprises Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 6th. Stockholders of record on Monday, February 26th were paid a $0.06 dividend. The ex-dividend date of this dividend was Friday, February 23rd. This represents a $0.24 dividend on an annualized basis and a dividend yield of 1.95%. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 133.33%.

Institutional Trading of Nu Skin Enterprises

A number of institutional investors and hedge funds have recently modified their holdings of NUS. GAMMA Investing LLC bought a new stake in shares of Nu Skin Enterprises in the 4th quarter valued at about $33,000. CWM LLC increased its stake in Nu Skin Enterprises by 5,838.9% during the 3rd quarter. CWM LLC now owns 2,138 shares of the company’s stock worth $45,000 after purchasing an additional 2,102 shares in the last quarter. Signaturefd LLC increased its stake in Nu Skin Enterprises by 240.7% during the 3rd quarter. Signaturefd LLC now owns 3,996 shares of the company’s stock worth $85,000 after purchasing an additional 2,823 shares in the last quarter. Counterpoint Mutual Funds LLC bought a new stake in Nu Skin Enterprises during the 3rd quarter worth approximately $124,000. Finally, New Mexico Educational Retirement Board bought a new stake in Nu Skin Enterprises during the 1st quarter worth approximately $145,000. 82.84% of the stock is owned by institutional investors.

Analysts Set New Price Targets

NUS has been the topic of several research reports. DA Davidson reduced their price target on shares of Nu Skin Enterprises from $29.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 5th. StockNews.com downgraded shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Saturday, February 24th. Four equities research analysts have rated the stock with a hold rating, According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $23.67.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.